Franklin Resources’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$54.1M	Buy	2,297,943 +397,859	+21%	+$10.2M	0.01%	624
2025 Q4	$55.2M	Sell	1,900,084 -410,935	-18%	-$10.5M	0.01%	608
2025 Q3	$43.6M	Sell	2,311,019 -421,758	-15%	-$6.65M	0.01%	691
2025 Q2	$38.3M	Sell	2,732,777 -28,990	-1%	-$406K	0.01%	712
2025 Q1	$43.2M	Sell	2,761,767 -547,552	-17%	-$7.71M	0.01%	653
2024 Q4	$46.1M	Sell	3,309,319 -941,099	-22%	-$10.3M	0.01%	642
2024 Q3	$41.4M	Sell	4,250,418 -187,761	-4%	-$1.85M	0.01%	666
2024 Q2	$41.3M	Sell	4,438,179 -204,281	-4%	-$1.85M	0.01%	606
2024 Q1	$46M	Sell	4,642,460 -13,084	-0.3%	-$97.7K	0.01%	595
2023 Q4	$15M	Buy	4,655,544 +3,363,191	+260%	+$9.14M	0.01%	826
2023 Q3	$6.86M	Sell	1,292,353 -360,183	-22%	-$3.06M	﹤0.01%	997
2023 Q2	$15.7M	Buy	1,652,536 +59,166	+4%	+$657K	0.01%	831
2023 Q1	$17.5M	Buy	1,593,370 +795,634	+100%	+$11.5M	0.01%	809
2022 Q4	$11.8M	Sell	797,736 -1,260	-0.2%	-$22K	0.01%	903
2022 Q3	$15.3M	Buy	798,996 +5,100	+0.6%	+$116K	0.01%	841
2022 Q2	$16.9M	Buy	793,896 +134,060	+20%	+$2.75M	0.01%	830
2022 Q1	$12.7M	Buy	659,836 +44,091	+7%	+$746K	0.01%	955
2021 Q4	$12.8M	Buy	615,745 +40,537	+7%	+$807K	﹤0.01%	990
2021 Q3	$13.7M	Sell	575,208 -520	-0.1%	-$11.9K	0.01%	987
2021 Q2	$15.7M	Sell	575,728 -77,280	-12%	-$2.18M	0.01%	922
2021 Q1	$18.9M	Buy	+653,008	New	+$20.4M	0.01%	849